Latest News
Independent asset manager Dunas Capital has launched the Rainforest Dunas Iberia Fund I FCR, the first private equity fund of funds that will invest exclusively in Spanish and Portuguese GPs.
The fund of funds manager will look for investment opportunities in buyout and growth capital funds but will also have some flexibility to invest in venture capital, private debt, infrastructure and special situations. With a target size of EUR100 million, Rainforest Dunas Iberia Fund I FCR plans to start making commitments to Iberian private equity firms in the next few months.
The fund is managed by Inverseguros Gestión, which
Palatine Private Equity has exited its investment in the telecoms arm of MJ Quinn following the sale to Visabeira/Constructel.
MJ Quinn, which is headquartered in Liverpool, specialises in the provision of a variety of telecoms services including access network solutions, fibre roll out for businesses and households and provision of energy efficient cooling solutions. Palatine initially backed the secondary buyout of the business in 2008 from its maiden GBP100 million fund.
Visabeira/Constructel is headquartered in France and is a major provider of telecommunication network infrastructure engineering with operations throughout Europe and Africa. The acquisition of MJ Quinn’s telecoms business
Talis Capital, a London-based VC family office focussed on early-stage technology companies and one of the largest investors, has announced a USD20 million seed funding round into Oh My Green, a concierge-style provider of healthy food and wellness services for corporations of all sizes.
Other investors that participated in the round included Y Combinator, Initialized Capital, Powerplant Ventures, Backed VC, ZhenFund, and Stanford-StartX Fund. The new capital will be used to further advance Oh My Green’s innovative wellness platform, which incorporates artificial intelligence and IoT technology to enhance supply chain management and improve personalization of the company’s food services. Additionally,
London-based investment fund, Fuel Ventures, has invested GBP500,000 in an on-demand manufacturing platform Manufacturingsource.com, which connects design and production engineers with suitable and trusted manufacturers to create custom parts.
The site, which has attracted a global network of engineers and manufacturers, allows customers to get instant quotes and place orders, from prototypes to full scale production, on a single platform.
Entrepreneurs Sam Al-Mukhtar and Will Hoyer Millar launched Manufacturingsource.com in 2017, after the pair realised there was a clear opportunity to address a known problem within the Manufacturing sector, which was last year estimated at GBP384.5 billion in the
Artivest, a provider of alternative funds and technology solutions, has appointed Kamal Jafarnia as General Counsel and Chief Compliance Officer.
Jafarnia (pictured), brings more than 25 years of experience as an attorney and compliance professional to this role, having advised public and private companies – including alternative investment program sponsors – on complex securities offerings, regulatory and compliance issues, mergers and acquisitions, and corporate governance.
Jafarnia plans to allocate his time between Artivest’s New York and San Diego headquarters, and reports directly to James Waldinger, Artivest’s Founder and Chief Executive Officer.
“As regulations governing wealth and investment management
Foresight Group (Foresight) has made a GBP1 million investment into Nottingham-based Alpkit Limited (Alpkit) on behalf of the Foresight Nottingham Fund, alongside bank funding provided by HSBC.
Alpkit is a fast-growing designer and retailer of outdoor clothing and equipment. Targeting the outdoor adventure enthusiast, Alpkit provides high quality clothing and equipment at an affordable price and offers over 500 lines across clothing, equipment and bikes. All products are designed at the Company’s HQ in Newthorpe, Nottingham, with a focus on technical performance, providing their customers with “gear that costs less but works harder.”
Alpkit was founded in 2004 by
Cordillera Investment Partners has held the final closing of its second fund, Cordillera Investment Fund II, with total commitments of USD362 million, bringing the total AUM of the firm to USD648 million.
The fund was oversubscribed and capitalised by endowments, foundations, family offices, and wealth advisors.
Cordillera specialises in unique and less correlated investment opportunities in areas that it believes remain inefficient, misunderstood, and not over-capitalised. The firm has completed investments in various areas including in music royalties, international arbitration, permanent crops and water rights, boat marinas, broadband spectrum licenses, commercial litigation finance, and environmental markets.
In addition
NorthEdge Capital has appointed experienced dealmaker Kevin O’Loughlin as an Investment Manager, based in Birmingham.
O’Loughlin joins NorthEdge from Deloitte, where he was Assistant Director for three years working on a range of transactions involving privately-owned and publicly-listed companies in the Midlands. These include the sale of Atcore to Inflexion Private Equity, the sale of Aegis Engineering to US buyer Safariland Group and Eddie Stobart’s acquisition of The Pallet Network.
Prior to Deloitte, O’Loughlin worked as part of EY’s Corporate Finance team, where he advised NorthEdge on investments including Ramsdens, the UK’s largest independent pawnbroker, which successfully floated on
Hedgeweek, in partnership with Intralinks, hosted a webinar to present the findings of a global LP survey that sought to determine investor sentiment towards general partners of alternative investment funds.
Why is this? What are the underlying dynamics at work that are impelling institutions to explore direct investments alongside their existing commingled and co-investment allocations? What benefits are they striving for? Which regions are they favoring?
Obviously there are associated risks to this, not least how such activity could impact LPs existing relationships with their GPs. Join the panel as they discuss the implications
Michael Nitka, Managing Director, Credit Investments,
CuraSen Therapeutics, a privately held biotechnology company focussed on developing therapies to treat neurodegenerative diseases, has closed a USD54.5 million Series A financing Led by New Leaf Venture Partners.
The investor syndicate also includes Longitude Capital, funds managed by Tekla Capital Management LLC, Alta Partners, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and Pappas Capital.
CuraSen is developing small molecule drugs targeting a novel mechanism in the brain to alleviate disabling symptoms and modify disease pathology in patients who suffer from less common (orphan) neurodegenerative disorders as well as Parkinson’s Disease and Alzheimer’s Disease. These symptoms include cognition,
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
